BA vs RYTM · P/E 89, rev $89.46B vs rev $130.1M
The Boeing Company (BA) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the BA and RYTM stock pages for the full models.
Not investment advice.